Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: A report from the Children's Oncology Group

Journal of Clinical Oncology

Volumn 30, Issue 21, 2012, Pages 2641-2647

  Ater, Joann L ^a   Zhou, Tianni ^c   Holmes, Emiko ^c   Mazewski, Claire M ^f   Booth, Timothy N ^b   Freyer, David R ^d   Lazarus, Ken H ^g   Packer, Roger J ^h   Prados, Michael ^e   Sposto, Richard ^d   Vezina, Gilbert ^h   Wisoff, Jeffrey H ⁱ   Pollack, Ian F ^j  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Children's Health Care of Atlanta   (United States)

^g INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ NEW YORK UNIVERSITY   (United States)

^j CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; LOMUSTINE; PROCARBAZINE; TIOGUANINE; VINCRISTINE;

AGE DISTRIBUTION; ALLERGIC REACTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEMALE; GLIOMA; HUMAN; INFECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NEUROTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; THALAMUS; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; WEAKNESS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBOPLATIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; HUMANS; INFANT; LOMUSTINE; MALE; MULTIVARIATE ANALYSIS; PROCARBAZINE; PROGNOSIS; RISK FACTORS; SPINAL CORD NEOPLASMS; THIOGUANINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 84864036181     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.6054     Document Type: Article

References (32)

1. Pollack IF: Brain tumors in children. N Engl J Med 331:1500-1507, 1994
2. Gajjar A, Sanford RA, Heideman R, et al: Low-grade astrocytoma: A decade of experience at St. Jude Children's Research Hospital. J Clin Oncol 15:2792-2799, 1997 (Pubitemid 27330005)
3. Merchant TE, Kun LE, Wu S, et al: Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol 27:3598-3604, 2009
4. Mulhern RK, Merchant TE, Gajjar A, et al: Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399-408, 2004 (Pubitemid 38878043)
5. Bowers DC, Liu Y, Leisenring W, et al: Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 24:5277-5282, 2006 (Pubitemid 46631374)
6. Mulder RL, Kremer LC, van Santen HM, et al: Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic review. Cancer Treat Rev 35:616-632, 2009
7. Sutton LN, Molloy PT, Sernyak H, et al: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 83:583-589, 1995
8. Collet-Solberg PF, Sernyak H, Satin-Smith M, et al: Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clin Endocrinol (Oxf) 47:79-85, 1997 (Pubitemid 27313992)
9. Merchant TE, Conklin HM, Wu S, et al: Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27:3691-3697, 2009
10. Reddy AT, Packer RJ: Chemotherapy for low-grade gliomas. Childs Nerv Syst 15:506-513, 1999 (Pubitemid 29493577)
11. Moore BD 3rd, Ater JL, Copeland DR: Improved neuropsychological outcome in children with brain tumors diagnosed during infancy and treated without cranial irradiation. J Child Neurol 7:281-290, 1992
12. Packer RJ, Lange B, Ater J, et al: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850-856, 1993 (Pubitemid 23146078)
13. Packer RJ, Ater J, Allen J, et al: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754, 1997 (Pubitemid 27187674)
14. Petronio J, Edwards MS, Prados M, et al: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74:701-708, 1991
15. Prados MD, Edwards MS, Rabbitt J, et al: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32:235-241, 1997 (Pubitemid 27077974)
16. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007 (Pubitemid 47103521)
17. Rubinstein LV, Gail MH, Santner TJ: Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chronic Dis 34:469-479, 1981 (Pubitemid 11002122)
18. Sposto R, Sather HN: Determining the duration of comparative clinical trials while allowing for cure. J Chronic Dis 38:683-690, 1985 (Pubitemid 16237418)
19. Demets DL: Group sequential procedures: Calendar versus information time. Stat Med 8:1191-1198, 1989
20. Sposto R: Cure model analysis in cancer: An application to data from the Children's Cancer Group. Stat Med 21:293-312, 2002
21. Mishra KK, Squire S, Lamborn K, et al: Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol 100:121-127, 2010
22. Lafay-Cousin L, Holm S, Qaddoumi I, et al: Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer 103:2636-2642, 2005 (Pubitemid 40800545)
23. Walter AW, Gajjar A, Reardon DA, et al: Tamoxifen and carboplatin for children with low-grade gliomas: A pilot study at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol 22:247-251, 2000 (Pubitemid 32268309)
24. Massimino M, Spreafico F, Cefalo G, et al: High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209-4216, 2002 (Pubitemid 35191023)
25. Massimino M, Spreafico F, Riva D, et al: A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol 100:65-71, 2010
26. Laithier V, Grill J, Le Deley MC, et al: Progression-free survival in children with optic pathway tumors: Dependence on age and the quality of the response to chemotherapy - Results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21:4572-4578, 2003 (Pubitemid 46594029)
27. Khaw SL, Coleman LT, Downie PA, et al: Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49:808-811, 2007 (Pubitemid 47519517)
28. Nicholson HS, Kretschmar CS, Krailo M, et al: Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: A report from the Children's Oncology Group. Cancer 110:1542-1550, 2007 (Pubitemid 47463069)
29. Packer RJ, Jakacki R, Horn M, et al: Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatr Blood Cancer 52:791-795, 2009
30. Yu J, Deshmukh H, Gutmann RJ, et al: Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology 73:1526-1531, 2009
31. Yan H, Parsons DW, Jin G, et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773, 2009
32. Jones DT, Kocialkowski S, Liu L, et al: Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 28:2119-2123, 2009